Journal Image
Current Psychiatry Reviews
ISSN (Print): 1573-4005
ISSN (Online): 1875-6441
DOI: 10.2174/157340009789542114      Price:  $58

Clinical Potential of Yi-Gan San (Yokukansan) for the Treatment of Psychiatric Disorders

Author(s): Tsuyoshi Miyaoka and Jun Horiguchi
Pages 271-275 (5)
Yi-gan san (YGS, yokukan-san in Japanese) was developed in 1555 by Xue Kai as a remedy for restlessness and agitation in children. Prompted by the increasing life expectancy of the Japanese population, geriatricians have begun to use this traditional regimen for behavioral and psychological symptoms of dementia in the elderly. Moreover, we reported that YGS therapy is a well-tolerated and effective remedy that improves the symptoms of borderline personality disorder and neuroleptics induced tardive dyskinesia. In a pilot investigation, we administered YGS as an open-label adjunct to antipsychotic medication to patients with treatment-resistant schizophrenia. The present review summarizes the available data supporting the clinical testing of YGS for psychiatric disorders. In addition, we extend our discussion to the potential applications of YGS for combining this treatment with cellular and molecular therapy.
Department of Psychiatry, Shimane University School of Medicine, 89-1 Enyacho, Izumo 693-8501, Japan.